Keyphrases
Accumbens Shell
30%
Agmatine
28%
Alkyl
28%
Antibody-mediated
21%
Anxiolytic Activity
14%
Arcuate nucleus
17%
Autoantibodies
32%
Autoimmune Encephalitis
22%
BIBP-3226
18%
Central Amygdala
37%
Chronic Pain
15%
Cocaine and Amphetamine Regulated Transcript
100%
Dopamine
16%
Encephalitis
25%
Epileptic Seizure
29%
Food Intake
16%
HS014
19%
Hyperalgesia
21%
Immunoreactivity
22%
Lever Press
18%
Locomotor Recovery
21%
Melanocortin 4 Receptor (MC4R)
28%
Monoclonal Antibody
15%
Morphine
57%
Morphine Withdrawal
15%
N-methyl-D-aspartate Receptor (NMDAR)
21%
N-methyl-D-aspartate Receptor Antibody
28%
Neurological Disorders
19%
Neuropathic Rats
28%
Neuropeptide Y
87%
Neuropeptide Y Receptor
57%
Neuropeptide Y System
19%
Neuroprotective Effect
28%
Neurosteroids
17%
Nicotine
28%
Nucleus Accumbens Shell
32%
Obesity
14%
Parkinson's Disease
53%
Rat Model
15%
Receptor Agonist
20%
Receptor Antagonist
25%
Rodent Models
19%
Seizure
37%
Seizure Models
17%
Self-stimulation
17%
Spatial Learning
19%
Spatial Memory
19%
Spinal Cord Injury
33%
Synaptic
19%
α-Melanocyte-stimulating Hormone (α-MSH)
19%
Neuroscience
Agmatine
28%
Allopregnanolone
14%
Alpha-Melanocyte-Stimulating Hormone
23%
Alzheimer's Disease
21%
Amygdala
19%
Antidepressant
14%
Arcuate Nucleus
16%
Aspartic Acid
28%
Autoantibodies
26%
Behavior (Neuroscience)
63%
Beta intermedin[11-22][11 (N Acetylcysteine) 14 [3 (2 Naphthyl) Dextro Alanine] 18 Cysteine 22 Aspartic Acid Amide] 11,18 Cyclic Disulfide
23%
Central Nucleus of the Amygdala
28%
Cerebellum
14%
Cocaine and Amphetamine Regulated Transcript
28%
Cocaine and Amphetamine Regulated Transcript Peptide
89%
Contactin
14%
Electrophysiology
17%
Electrotherapy
15%
Encephalitis
26%
Epileptic Seizure
15%
Fluoxetine
14%
Hyperalgesia
34%
Ictal
20%
Imidazoline Receptor
14%
Imipramine
14%
In Vitro
25%
In Vivo
24%
L-DOPA
14%
Leucine
14%
Medial Forebrain Bundle
15%
Melanocortin 4 Receptor
28%
Melanocyte-Stimulating Hormone
26%
Monoclonal Antibody
15%
Morphine
57%
Motor Coordination
14%
Neuropeptide Y
100%
Neuroprotective Agent
32%
Neurosteroid
19%
Nociception
14%
Nucleus Accumbens Shell
31%
Olanzapine
14%
Parkinson's Disease
28%
Receptor
73%
Receptor Antagonist
24%
Receptor Antibody
28%
Receptor Protein
14%
Serotonergic
14%
Spinal Cord Injury
46%
Synaptic Transmission
19%
Ventral Tegmental Area
17%
Pharmacology, Toxicology and Pharmaceutical Science
Agmatine
28%
Allergic Encephalitis
6%
Alzheimer's Disease
25%
Amphetamine
28%
Antidepressant Activity
14%
Antipsychotic
5%
Aspartic Acid
28%
Autoantibodies
18%
Behavioral Neuropharmacology
7%
Beta intermedin[11-22][11 (N Acetylcysteine) 14 [3 (2 Naphthyl) Dextro Alanine] 18 Cysteine 22 Aspartic Acid Amide] 11,18 Cyclic Disulfide
14%
Causal Modeling
9%
Cocaine and Amphetamine Regulated Transcript Peptide
46%
Diseases
55%
Dopamine Receptor Stimulating Agent
5%
Encephalitis
33%
Fluoxetine
14%
Huntington Chorea
7%
Hydrogen Peroxide
7%
Hydrogen Sulfide
14%
Hyperalgesia
32%
Imidazoline Receptor
14%
Imipramine
14%
Levodopa
14%
Melanocortin 4 Receptor
14%
Methylprednisolone
9%
Morphine
28%
Nalpha (Diphenylacetyl) N (4 Hydroxybenzyl) Dextro Argininamide
5%
Neuropathic Pain
7%
Neuropeptide
5%
Neuropeptide Y
28%
Neuroprotective Agent
32%
Neurosteroid
19%
Olanzapine
14%
Parkinson's Disease
60%
Peptide Antibody
6%
Polyvinyl Alcohol
14%
Pregnenolone Sulfate
9%
Rat Model
28%
Receptor
55%
Receptor Agonist
6%
Receptor Antagonist
20%
Receptor Antibody
42%
Spinal Cord Injury
32%
Table Salt
28%
Transdermal Delivery
14%
Trehalose
10%